Cargando…
The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad
Gujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%.
Autor principal: | Shah, Sandip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902622/ https://www.ncbi.nlm.nih.gov/pubmed/24516307 http://dx.doi.org/10.4103/0971-5851.123729 |
Ejemplares similares
-
Leprosy Scenario in Ahmedabad District (Gujarat)
por: Uikey, Deepika, et al.
Publicado: (2019) -
Report of patients with chronic myeloid leukemia, from hematology clinic, Ahmedabad, Gujarat 2000-2010 at 1(st) myelostone meeting: Indian evidence of chronic myelogenous leukemia
por: Deotare, Uday R., et al.
Publicado: (2013) -
Awareness and knowledge of cervical cancer and its prevention among the nursing staff of a tertiary health institute in Ahmedabad, Gujarat, India
por: Shah, V, et al.
Publicado: (2012) -
Epidemic Investigation of the Jaundice Outbreak in Girdharnagar, Ahmedabad, Gujarat, India, 2008
por: Chauhan, Naresh T, et al.
Publicado: (2010) -
Study on prevalence of Fasciolosis in buffaloes at Anand and Ahmedabad districts, Gujarat, India
por: Pandya, Suchit S., et al.
Publicado: (2015)